Showing results (281-290 of 294) with videos related to
Sort By:
Pageof 30
F1000Research|November 3, 2020
The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 daysPerrine Janiaud, Cathrine Axfors, Janneke Van't Hooft, et al.Journal of Clinical Epidemiology|October 3, 2020
Developing trustworthy recommendations as part of an urgent response (1-2 weeks): a GRADE concept paperElie A Akl, Rebecca L Morgan, Andrew A Rooney, et al.The Journal of Pediatrics|April 15, 2017
Premature Discontinuation of Pediatric Randomized Controlled Trials: A Retrospective Cohort StudyStefan Schandelmaier, Yuki Tomonaga, Dirk Bassler, et al.BMJ Evidence-Based Medicine|April 16, 2022
Which actionable statements qualify as good practice statements In Covid-19 guidelines? A systematic appraisalOmar Dewidar, Tamara Lotfi, Miranda Langendam, et al.BMJ (Clinical Research Ed.)|July 18, 2014
Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publicationsBenjamin Kasenda, Stefan Schandelmaier, Xin Sun, et al.JAMA|March 13, 2014
Prevalence, characteristics, and publication of discontinued randomized trialsBenjamin Kasenda, Erik von Elm, John You, et al.Plos Medicine|June 29, 2016
Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical TrialsBenjamin Kasenda, Erik von Elm, John J You, et al.Annals of Internal Medicine|January 19, 2026
GRADE Guidance: Update on Developing Good Practice Statements in GuidelinesOmar Dewidar, Elie A Akl, Gian Paolo Morgano, et al.Critical Care Medicine|October 16, 2015
Premature Discontinuation of Randomized Trials in Critical and Emergency Care: A Retrospective Cohort StudyStefan Schandelmaier, Erik von Elm, John J You, et al.Plos Medicine|April 27, 2022
Nonregistration, discontinuation, and nonpublication of randomized trials: A repeated metaresearch analysisBenjamin Speich, Dmitry Gryaznov, Jason W Busse, et al.Pageof 30